p -methyl-phenethylamine    ,
    Further details on identity and specification of active substance are provided in the review report.    ,

  Iprovalicarb    CAS No 140923-17-7    CIPAC No 620  ,isopropyl [(1S)-2-methyl-1-{[(1RS)-1-p-tolylethyl]carbamoyl}propyl]carbamate,  ≥ 950 g/kg    Impurities:    Toluene: not more than 3 g/kg  ,1 April 2016,31 March 2031,  For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on iprovalicarb, and in particular Appendices I and II thereto, shall be taken into account.    In this overall assessment Member States shall pay particular attention to:      the protection of groundwater from the relevant soil metabolite PMPA when the active substance is applied in regions with low clay containing soil types,      the safety of operators and workers,      the protection of aquatic organisms in the case of formulated products containing other active substances.      Conditions of use shall include risk mitigation measures, where appropriate.    The applicant shall submit to the Commission, the Member States and the Authority, confirmatory information as regards the genotoxic potential of soil metabolite PMPA. This information shall be submitted by 30 September 2016.  ,
     p -methyl-phenethylamine’    ,
    Further details on identity and specification of active substance are provided in the review report.    ,

‘96,  Iprovalicarb    CAS No 140923-17-7    CIPAC No 620  ,isopropyl [(1S)-2-methyl-1-{[(1RS)-1-p-tolylethyl]carbamoyl}propyl]carbamate,  ≥ 950 g/kg    Impurities:    Toluene: not more than 3 g/kg  ,1 April 2016,31 March 2031,  For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on iprovalicarb, and in particular Appendices I and II thereto, shall be taken into account.    In this overall assessment Member States shall pay particular attention to:      the protection of groundwater from the relevant soil metabolite PMPA when the active substance is applied in regions with low clay containing soil types,      the safety of operators and workers,      the protection of aquatic organisms in the case of formulated products containing other active substances.      Conditions of use shall include risk mitigation measures, where appropriate.    The applicant shall submit to the Commission, the Member States and the Authority, confirmatory information as regards the genotoxic potential of soil metabolite PMPA. This information shall be submitted by 30 September 2016.  ,